Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Lymphocyte-Activation Gene 3 (LAG3) (C-Term) Peptide

LAG3 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN8104630
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour Lymphocyte-Activation Gene 3 (LAG3) (C-Term) Peptide (ABIN8104630)

Antigène

LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Origine

Humain

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Fonction

    LAG3 Peptide - C-terminal region

    Séquence

    GFHLWRRQWR PRRFSALEQG IHPPQAQSKI EELEQEPEPE PEPEPEPEPE
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti-LAG3 Antibody(ARP59142_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

    Sujet

    Background Information: Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4.

    Alternative Symbols: CD223

    Poids moléculaire

    55kDa

    ID gène

    3902

    NCBI Accession

    NP_002277

    UniProt

    P18627
Vous êtes ici:
Chat with us!